Voyager Therapeutics, Inc. (VYGR) is a biotechnology company focused on developing therapeutic products for neurological disorders. With a deep understanding of the brain and nervous system, Voyager Therapeutics aims to transform the treatment of these complex diseases through gene therapy. Their research focuses on utilizing adeno-associated viruses to deliver therapeutic genes to the brain and restore normal functions. The company seeks to provide new possibilities for patients with neurodegenerative diseases. Voyager Therapeutics, Inc. (VYGR) shares could be suitable for investors who wish to support innovative developments in treatment approaches within the field of neurology and contribute to improving the quality of life for patients.